Endocyte Inc.

Endocyte Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$1.37 B
Shares Outstanding
70.01 M
Public Float
56.49 M


3000 Kent Avenue
West Lafayette Indiana 47906
United States
Employees -
Website http://www.endocyte.com
Updated 09/14/2018
Endocyte, Inc. is a biopharmaceutical company, which engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells.


View All

Michael A. Sherman
President, Chief Executive Officer & Director
Philip S. Low
Director & Chief Science Officer